Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bicycle Therapeutics names business chief

This article was originally published in Scrip

Executive Summary

Cambridge, UK-based Bicycle Therapeutics, an emerging biotech company developing first-in-class bicyclic peptide targeted drugs, has named Arvind Hundal president and chief business officer. Dr Hundal has more than 20 years' experience in the life sciences sector, the majority of which have been in business development and strategy roles. She was most recently chief business officer and senior management team member at Zealand Pharma and was a part of the team that lead the successful initial public offering in 2010.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC028735

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel